Ambalal Sarabhai spurts after JV gets nod for HCV viral load kit

21 Apr 2022 , 10:17 AM

CoSara Diagnostics recently got permission to manufacture and sell its SARAQ Hepatitis C (HCV) viral load kit as an in-vitro diagnostic (IVD) from Central Drugs Standard Control Organisation (CDSCO).

CoSara Diagnostics a joint venture of a subsidiary of Ambalal Sarabhai Enterprises and US-based Co-Diagnostics.

This HCV Viral Load kit test adds to our expanding menu of valuable diagnostic tools available to our growing distributor and laboratory customer base, Ambalal Sarabhai said in a statement.

The approval marks the 14th IVD to receive clearance by the CDSCO. Effective HCV treatments are especially useful when used in tandem with tests for diagnosing and monitoring those therapies, the company said.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products and bulk drugs.

On a consolidated basis, net profit of Ambalal Sarabhai Enterprises rose 73.27% to Rs 3.50 crore on 6.41% decline in net sales to Rs 43.10 crore in Q3 December 2021 over Q3 December 2020.

Powered by Capital Market – Live News